Scotland · NHS Scotland MSAN
Bumetanide 1mg and 5mg tablets
MSAN(2023)33 · Level 3 · issued 16 Oct 2023
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Bumetanide 5mg tablets are out of stock until early March 2024. | Out of stock | early March 2024 |
| 2. Bumetanide 1mg tablets remain available until the end of October and will be out of stock until | Out of stock | the end of October and will be out of stock until |
| 3. Bumetanide 1mg/5ml SF oral solution remains available but is unable to support increased | Available | — |
| 4. Furosemide 20mg and 40mg tablets remain available and can support increased demand. | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2023:33
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
2a6ce6465299d838fa2d0f2bd498ec4753ea1475abff5383538588a12674c62bsha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2023-33.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.